A vaccine made for one person's cancer kept melanoma from returning

Moderna and Merck's personalized shot is built from the unique genetic fingerprints of each patient's own tumor, training the immune system to hunt down leftover cancer cells. In trial results it cut the risk of the deadly skin cancer coming back — pointing to a future where cancer vaccines are made to measure.